Endpoints Cell and Gene Day, April 29, 11:00 – 13:00 PM
Ori Biotech CEO Jason C. Foster joined industry experts to explore new and emerging treatments and unpack the business strategies that might keep the industry moving forward.
11:35 – 12:05 ET | Avoiding failure: The path to commercial viability for CGTs
Tackling the economic challenges that hold back scalable CGT manufacturing and access.
Panel:
Jason C. Foster, CEO, Ori Biotech
Mark Bamforth, CEO, Kincell Bio
Daniel Palmacci, President, Cell & Gene Division, Lonza
Andrew Snowden, Senior Director, CAR-T Cell Therapy Process Development, Johnson and Johnson
Moderator: Surani Fernando, Healthcare Journalist, Writer and Podcast Producer for Raising Biotech